Top Stocks
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
ETF Center
SPY ETF
QQQ ETF
Stock Comparison
ChatGPT Stocks
Value Stocks
Airline Stocks
AI Stocks
Oil Stocks
Bank Stocks
FAANG Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
Top Experts
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
EXEL
Stock Latest News
The Fly
Biotech Alert: Searches spiking for these stocks today
5d ago
CDTX
EVFM
The Fly
Jefferies says ‘activist has a point’ on Exelixis R&D
6d ago
EXEL
The Fly
Exelixis announces $550M share repurchase program
8d ago
EXEL
The Fly
Exelixis initiated with an Overweight at Wells Fargo
19d ago
EXEL
The Fly
Exelixis says Phase 3 CONTACT-03 study did not meet its primary endpoint
25d ago
EXEL
The Fly
Bristol-Myers’ Opdivo and Exelixis’ Cabometyx show durable survival in carcinoma
1M ago
BMY
EXEL
The Fly
Exelixis, Sairopa announce FDA clearance for ADU-1805 IND application
1M ago
EXEL
The Fly
Exelixis sees FY23 revene $1.775B-$1.875B, consensus $1.84B
2M ago
EXEL
The Fly
Exelixis reports Q4 EPS (3c), consensus (12c)
2M ago
EXEL
The Fly
Exelixis options imply 3.8% move in share price post-earnings
2M ago
EXEL
Stock Analysis & Ideas
Credit Suisse Says These 2 Stocks Could Surge Over 30% From Current Levels
2M ago
BYD
EXEL
The Fly
Credit Suisse bullish on Exelixis, initiates with an Outperform
2M ago
EXEL
The Fly
Exelixis initiated with an Outperform at Credit Suisse
2M ago
EXEL
The Fly
William Blair says Exelixis cabozantinib patent verdict in line with expectation
2M ago
EXEL
Market News
Court Rulings Bring Good and Bad News for Exelixis (NASDAQ:EXEL)
2M ago
EXEL
The Fly
Exelixis receives favorable ruling in patent litigation with MSN Laboratories
2M ago
EXEL
The Fly
Exelixis, Ajinomoto enter license agreement
3M ago
EXEL
The Fly
Exelixis price target lowered to $20 from $21 at Cowen
3M ago
EXEL
The Fly
Exelixis reports preliminary Q4 revenue $415M, consensus $414.83M
3M ago
EXEL
The Fly
NccRCC ‘material expansion opportunity’ for Exelixis, says William Blair
3M ago
BMY
EXEL
The Fly
Exelixis announces initiation of STELLAR-304 Phase 3 trial of zanzalintinib
3M ago
BMY
EXEL
The Fly
Exelixis names Dana Aftab next chief scientific officer
3M ago
EXEL
Show More
You need to enable JavaScript to run this app.